IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Study of the Therapeutic Vaccine (ISA101/ISA101b) to Treat Advanced or Recurrent Cervical Cancer (CervISA)
This study is currently recruiting participants.
Verified April 2017 by ISA Pharmaceuticals
Sponsor:
ISA Pharmaceuticals
Collaborator:
Dutch Cancer Society
Information provided by (Responsible Party):
ISA Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT02128126
First received: April 18, 2014
Last updated: April 4, 2017
Last verified: April 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | September 2021 |
| Estimated Primary Completion Date: | September 2017 (Final data collection date for primary outcome measure) |